DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Menard C, Blay JY, Borg C et al.
Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.
Cancer Res 2009;
69: 3563-3569
We do not assume any responsibility for the contents of the web pages of other providers.